Pfizer, Inc. : Increase of volatility
Entry price | Target | Stop-loss | Potential |
---|
US$38.54 |
US$43.9 |
US$34.4 |
+13.91% |
---|
Pfizer, Inc. shares have been in strong demand lately. The technical chart pattern looks positive which may give rise to new gains.
Strengths● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
Weaknesses● Stock prices approach a strong long-term resistance in weekly data at USD 40.51.
● Technically, the stock approaches a strong medium-term resistance at USD 38.56.
● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
● The group usually releases earnings worse than estimated.
● With an enterprise value anticipated at 4.97 times the sales for the current fiscal year, the company turns out to be overvalued.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.